In:
British Journal of Dermatology, Oxford University Press (OUP), Vol. 188, No. 6 ( 2023-05-24), p. 810-812
Abstract:
This post hoc analysis evaluated efficacy and safety of roflumilast cream in patients with psoriasis involving the face/neck or intertriginous areas from a phase IIb trial. Of 331 patients enrolled in the phase IIb trial, 160 had psoriasis involving the face/neck and/or intertriginous areas. Once-daily roflumilast cream was well tolerated with efficacy across multiple endpoints in these patients.
Type of Medium:
Online Resource
ISSN:
0007-0963
,
1365-2133
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2023
detail.hit.zdb_id:
2004086-6